Corrigendum to "Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension" [J Hepatol 62 (2015) 325-331].
作者信息
Mookerjee Rajeshwar P, Mehta Gautam, Balasubramaniyan Vairappan, Mohamed Fatma El Zahraa, Davies Nathan, Sharma Vikram, Iwakiri Yasuko, Jalan Rajiv
机构信息
Liver Failure Group, Institute for Liver and Digestive Health, University College London, UK.
Liver Failure Group, Institute for Liver and Digestive Health, University College London, UK.
出版信息
J Hepatol. 2017 Nov;67(5):1124. doi: 10.1016/j.jhep.2017.08.004.
PMID:28893453
Abstract
摘要
Zotero 插件